Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease

Clinical trial NCT02913508 · WITHDRAWN

Trial details

NCT number: NCT02913508
Sponsor: Takeda
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis Crohn's Disease

Start date: 2014-04-01
Primary completion: 2015-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.